Company: NeoGenomics Laboratories
Job title: Chief Scientific Officer
Dr. Weiss received his BS summa cum laude and M.D. summa cum laude from the University of Maryland. He completed a residency in Anatomic Pathology at the Brigham and Women’s Hospital and a fellowship in surgical pathology at Stanford University Medical Center. He was previously an Assistant Professor of Pathology at Stanford, President of the Medical Staff, and Chairman of Pathology at the City of Hope.
Dr. Weiss is the author of over 500 papers and book chapters, as well as over a dozen books, including an AFIP Lymph Node Fascicle, Applied Immunohistochemistry, Lymph Nodes, and Knowles’ Hematopathology. His laboratory discovered the first molecular evidence linking the Epstein-Barr virus with Hodgkin Lymphoma.
He has won numerous awards, including the Benjamin Castleman, Arthur Purdy Stout, and the United States-Canadian Academy of Pathology Young Investigator Award, and has delivered more than 250 national and international talks in pathology, including several named lectureships. He is on the editorial board of ten scientific journals, and is a past President of the Los Angeles Society of Pathologists. He has been listed in the book The Best Doctors in America since 1994. Dr. Weiss’s diagnostic interests lie in lymph node pathology, adrenal pathology, solid tumor pathology, and immunohistochemistry.
Panel Discussion: Hemato-Oncology: can we turn MRD into a new opportunity for CDx and beyond? 10:00 am
day: Day Two
Moving Diagnostic Providers to the Forefront of Precision Medicine 9:00 am
• Role of the Diagnostic Laboratory in CDx commercialization – Key Considerations and Day 1 Readiness • CDx Case Studies including PIK3CA – discussing the full spectrum of CDx development from bench to bedside • Lab Challenges: Perspectives on lessons learned and future paradigms for CDx/Dx developmentRead more
day: Day One